Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlpine Immune Sc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Alpine Immune Sc Earnings Date And Information
Alpine Immune Sc last posted its earnings results on Thursday, May 9th, 2024. The company reported $-0.28 earnings per share for the quarter, topping analysts' consensus estimates of $-0.43 by $0.15. The company had revenue of 7.03 M for the quarter and had revenue of 58.88 M for the year. Alpine Immune Sc has generated $-1 earnings per share over the last year ($-0.64 diluted earnings per share) and currently has a price-to-earnings ratio of -100.94. Alpine Immune Sc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Alpine Immune Sc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/09/2024 | Q1 2024 | -$0.43 | -$0.28 | 0.15 | $7.03 M | $7.03 M |
| 03/19/2024 | Q4 2023 | N/A | $0.10 | N/A | $9.10 M | $30.85 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.24 | N/A | $7.25 M | $10.04 M |
| 08/14/2023 | Q2 2023 | -$0.38 | -$0.27 | 0.11 | $7.08 M | $8.59 M |
| 05/11/2023 | Q1 2023 | -$0.37 | -$0.23 | 0.14 | $6.88 M | $9.39 M |
| 03/23/2023 | Q4 2022 | -$0.27 | -$0.41 | -0.14 | $10.96 M | $2.78 M |
| 11/14/2022 | Q3 2022 | -$0.10 | -$0.40 | -0.3 | $18.69 M | $8.37 M |
| 08/11/2022 | Q2 2022 | -$0.39 | -$0.60 | -0.21 | $10.04 M | $5.29 M |
| 05/12/2022 | Q1 2022 | -$0.17 | -$0.25 | -0.08 | $16.26 M | $13.63 M |
| 03/17/2022 | Q4 2021 | -$0.26 | -$0.52 | -0.26 | $13.97 M | $4.53 M |
| 11/10/2021 | Q3 2021 | -$0.00 | -$0.55 | -0.55 | $21.19 M | $8.52 M |
| 08/10/2021 | Q2 2021 | -$0.29 | -$0.46 | -0.17 | $7.77 M | $7.19 M |
| 05/13/2021 | Q1 2021 | -$0.32 | -$0.45 | -0.13 | $6.67 M | $3.20 M |
| 03/18/2021 | Q4 2020 | -$0.27 | -$0.27 | 0 | $3.10 M | $5.64 M |
| 11/12/2020 | Q3 2020 | -$0.23 | -$0.28 | -0.05 | $5.10 M | $1.91 M |
| 08/11/2020 | Q2 2020 | -$0.23 | -$0.53 | -0.3 | $2.13 M | $688.00 K |
| 05/14/2020 | Q1 2020 | -$0.48 | -$0.30 | 0.18 | $376.67 K | $1.09 M |
| 03/30/2020 | Q4 2019 | -$0.55 | -$0.33 | 0.22 | $183.33 K | $884.00 K |
| 11/14/2019 | Q3 2019 | N/A | -$0.62 | N/A | $250.00 K | $289.00 K |
| 08/13/2019 | Q2 2019 | -$0.65 | -$0.64 | 0.01 | $83.33 K | $567.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alpine Immune Sc Earnings: FAQ's
In the previous quarter, Alpine Immune Sc (:ALPN) reported $-0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.43 by $0.15.
The conference call for Alpine Immune Sc's latest earnings report can be listened to online.
The conference call transcript for Alpine Immune Sc's latest earnings report can be read online.
Alpine Immune Sc (:ALPN) has a recorded annual revenue of $58.88 M.
Alpine Immune Sc (:ALPN) has a recorded net income of $-32,184,000.Alpine Immune Sc has generated $-0.64 earnings per share over the last four quarters.
Alpine Immune Sc (:ALPN) has a price-to-earnings ratio of -100.94 and price/earnings-to-growth ratio is -1.27.